Patients' willingness to pay for autologous blood donation

Lee, Stephanie J.; Neumann, Peter J.; Churchill, W. Hallowell; Cannon, Marie E.; Weinstein, Milton C.; Johannesson, Magnus

doi:10.1016/s0168-8510(96)00879-2

Cited by 46 publications

(42 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Researchers are starting to branch out and ask WTP about other issues. One study, for example, asked people what they would be willing to pay for autologous blood donations to reduce the risk of contracting blood-borne illnesses [4]. Fourth, as mentioned above, there is a consistent positive relationship between WTP and ability to pay, as measured by household income.…”

Section: Introductionmentioning

confidence: 96%

See 1 more Smart Citation

Willingness to pay for mammography: item development and testing among five ethnic groups

Wagner

Hu²,

Dueñas

et al. 2000

Health Policy

View full text Add to dashboard Cite

The goal of this study was to develop a willingness to pay (WTP) question for mammography that is appropriate for low income, ethnically-diverse women. Through qualitative research with 50 low income women of five ethnic groups we developed both a WTP question and a willingness to travel question (WTT). After being refined through interviews with 41 women, these questions were pilot tested on a random sample of 52 low income, ethnically-diverse women in the San Francisco area. Results show that the concepts underlying WTP and WTT were culturally appropriate to the five ethnicities in this study. Analyses generally confirm the validity of the WTP and WTT questions. As expected, WTP was associated with household income, perceived risk of cancer, and knowledge that one needs a mammogram even after a clinical breast examination. Despite the small samples, WTP varied among the ethnic groups. Additionally, WTT was moderately correlated with the natural log of WTP (r = 0.58, P < 0.001). These questions are now in use in a larger clinical trial and future analyses will explore willingness to pay and willingness to travel within and across the ethnic groups.

show abstract

Section: Introductionmentioning

confidence: 96%

“…Reported response rates have been as low as 45% [4]. Higher response rates were more typical among interviewer-administered surveys, which, for practical reasons, tend to be less common than postal surveys.…”

Section: Introductionmentioning

confidence: 99%

Willingness to pay for mammography: item development and testing among five ethnic groups

Wagner

Hu²,

Dueñas

et al. 2000

Health Policy

View full text Add to dashboard Cite

show abstract

“…Health-economic evaluation of newly introduced healthcare interventions is now widespread in healthcare decision-making processes across the world [1]. It is part of the Health Technology Assessment (HTA) programmes, which include issues such as clinical effectiveness, safety and cost-effectiveness within a broad field of social, ethical and legal aspects required for a new intervention to obtain local approval of reimbursement [2].…”

Section: Introductionmentioning

confidence: 99%

Towards a more comprehensive approach for a total economic assessment of vaccines?

Standaert

Rappuoli²

2017

Journal of Market Access & Health Policy

View full text Add to dashboard Cite

ABSTRACTSince we were born, we all take preventative actions to avoid unpredictable adverse conditions. Some actions are done automatically. Others require a conscious choice , either for personal or social benefit. A distinction can therefore be drawn between non-active and active prevention, and between individual and social prevention. Active prevention requires making a choice in time, effort, and cost. We call it an economic choice. Vaccines belong to the group of active and social prevention. Because a vaccination program is an economic social choice, how should it be valued, and what cost should we pay for? To date, the economic evaluations developed for treatment have been applied to vaccines. However, over 25 different characteristics differentiate vaccines from treatment. For example, the benefit of vaccination is measured at the population level not at the individual level, the main effect of prevention is societal and not an individual-based gain only, and the biggest hurdle to implement a new vaccine is the initial budget investment and not so much its estimated ‘value for money’. This makes the current application of incremental cost-utility analysis difficult for vaccines for a comprehensive evaluation. New approaches may be needed to capture the full economic benefit of vaccines.

show abstract

“…This approach has been used to generate monetary values for abstract quantities, such as water quality, to evaluate preferences for health products, [23][24][25][26][27] to evaluate societal preferences for health states, 28 and to determine acceptable rates of treatment failure for diabetic foot osteomyelitis. 19 The "take it or leave it" strategy that we used may better approximate real-life decision making, 29 and it may be less prone to framing and anchoring biases, 19,20,30 compared with open-ended strategies.…”

Section: Resultsmentioning

confidence: 99%

Measuring Acceptable Treatment Failure Rates for Community-Acquired Pneumonia: Potential for Reducing Duration of Treatment and Antimicrobial Resistance

Kaye

Harris

McDonald

et al. 2008

Infect. Control Hosp. Epidemiol.

View full text Add to dashboard Cite

Objective.This study was designed to establish the rates of treatment failure for community-acquired pneumonia that are acceptable to knowledgeable and experienced physicians, in order to facilitate the interpretation of existing studies and the design of new studies aimed at optimizing the duration of antibiotic therapy. Reducing the duration of antibiotic therapy is one strategy for reducing antibiotic exposure and thereby minimizing the potential for the emergence of antimicrobial resistance.Design.Survey soliciting the acceptable failure rate for treatment given to an adult patient with uncomplicated community-acquired pneumonia treated with standard-of-care therapy in the outpatient setting. Analysis was performed using a modification of established methods of contingent valuation analysis.Participants.Six hundred eighty infectious diseases physicians in North America who were also members of the Emerging Infections Network of the Infectious Diseases Society of America.Results.Three hundred seventy-five (55.1%) of 680 physicians responded to the survey. The median acceptable failure rate for treatment was 13.5%. Five hundred ten respondents (75.0%) found a failure rate of 7.3% acceptable, and 170 respondents (25.0%) found a failure rate of 19.8% acceptable.Conclusions.This study identified the failure rates for treatment of community-acquired pneumonia that were acceptable to infectious disease physicians. This range of acceptable treatment failure rates may facilitate the design of studies aimed at optimizing the duration of antimicrobial therapy for community-acquired pneumonia.

show abstract

Patients' willingness to pay for autologous blood donation

Cited by 46 publications

References 39 publications

Willingness to pay for mammography: item development and testing among five ethnic groups

Willingness to pay for mammography: item development and testing among five ethnic groups

Towards a more comprehensive approach for a total economic assessment of vaccines?

Measuring Acceptable Treatment Failure Rates for Community-Acquired Pneumonia: Potential for Reducing Duration of Treatment and Antimicrobial Resistance

Contact Info

Product

Resources

About